No alterations in α-synuclein gene dosage observed in sporadic Parkinson's disease
- 21 March 2006
- journal article
- letter
- Published by Wiley in Movement Disorders
- Vol. 21 (5) , 731-732
- https://doi.org/10.1002/mds.20863
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Alpha‐synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patientsMovement Disorders, 2005
- Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's diseaseNeuroscience Letters, 2005
- Failure to Find α-Synuclein Gene Dosage Changes in 190 Patients With Familial Parkinson DiseaseArchives of Neurology, 2005
- α-synuclein locus duplication as a cause of familial Parkinson's diseasePublished by Elsevier ,2004
- Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's diseaseThe Lancet, 2004
- α-Synuclein missense and multiplication mutations in autosomal dominant Parkinson’s diseaseNeuroscience Letters, 2004
- Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplicationsAnnals of Neurology, 2004
- Multiplication of the α-Synuclein Gene Is Not a Common Disease Mechanism in Lewy Body DiseaseJournal of Molecular Neuroscience, 2004
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001